Despite all the benefits of drug-eluting stents (DES), concerns have been raised over their long-term safety, with particular reference to stent thrombosis. In an effort to address these concerns, newer stents have been developed that include: DES with biodegradable polymers, DES that are polymer free, stents with novel coatings, and completely biodegradable stents. Many of these stents are currently undergoing pre-clinical and clinical trials; however, early results seem promising. This paper reviews the current status of this new technology, together with other new coronary devices such as bifurcation stents and drug-eluting balloons, as efforts continue to design the ideal coronary stent.
Takashi Muramatsu, Yoshinobu Onuma, Yao‐Jun Zhang, Christos V. Bourantas, Alexander Kharlamov, Roberto Diletti, Vasim Farooq, Bill D. Gogas, Scot Garg, Héctor M. García‐García, Yukio Ozaki, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.